. 2014 Aug 11;2014:192906. doi: 10.1155/2014/192906

Table 2.

Protective effect of PCEB on hematological parameters.

Treatment	Leukocyte ×10³/mm³	Neutrophil ×10³/mm³	Lymphocyte ×10³/mm³	Eosinophil ×10³/mm³	Monocyte ×10³/mm³	Hemoglobin (mg/dL)
Control	5.3 ± 0.02^a	61.6 ± 2.1^b	36.3 ± 1.5^d	1.5 ± 0.3^d	1.7 ± 0.01^d	13.7 ± 0.20^a
CCl₄ 1 mL/kg	4.6 ± 0.32^d	57.3 ± 1.5^d	48.6 ± 3.1^a	2.6 ± 0.2^a	2.8 ± 0.10^a	11.9 ± 0.15^d
CCl₄+Silymarin	5.1 ± 0.55^b	59.5 ± 0.4^c	37.0 ± 1.0^c	1.6 ± 0.1^c	1.8 ± 0.07^c	13.7 ± 0.40^a
CCl₄+PCEB 200 mg/kg	4.9 ± 0.25^c	67.7 ± 0.2^a	41.3 ± 1.5^b	1.9 ± 0.1^b	2.1 ± 0.32^b	13.2 ± 0.10^c
CCl₄+PCEB 400 mg/kg	5.2 ± 0.47^bc	65.7 ± 0.2^a	37.5 ± 1.5^c	1.7 ± 0.1^bc	1.9 ± 0.50^c	13.4 ± 0.20^b
PCEB 400 mg/kg	5.2 ± 0.17^b	59.0 ± 1.0^b	36.9 ± 0.2^d	1.4 ± 0.1^e	1.8 ± 0.04^cd	13.6 ± 0.40^a
Vehicle control	5.3 ± 0.18^a	61.2 ± 0.4^b	35.8 ± 1.0^bd	1.5 ± 0.1^d	1.7 ± 0.05^d	13.5 ± 0.01^ab

Mean ± SD (n = 6). Means with different letters (a–e) indicate significance at P < 0.05.